Divarasib led to significantly longer progression-free and overall survival compared with control treatment.

Researchers evaluated whether malnutrition independently increases the risk of chemotherapy-induced cardiovascular toxicity in patients with colorectal cancer.

Persistent pancytopenia following gynecologic cancer treatment warrants evaluation for t-MDS, a secondary malignancy associated with poor outcomes.